Updated 19 August 2021
The CanSino vaccine was one of the first vaccines created by China to aid people with the pandemic and given on a priority basis to smaller, developing nations, and others with bilateral agreements with China.
Here is everything you need to know about the Cansino vaccine and its usage across the world.
Table of Contents
According to a review of late-stage studies, CanSino Biologics Inc.’s investigational coronavirus vaccine has a 65.7 percent effectiveness rate in preventing symptomatic infections. This makes Pakistan’s CanSino vaccine one of the better contenders in the various vaccines coming up.
Various countries like Mexico, Pakistan, Malaysia, and more, are in talks (or already have) received supplies of vaccines from China, the nation that created CanSino. In addition, China plans to extend help to various other countries. This single-shot vaccine has proven to be essential for developing nations like Pakistan – who may not have the logistical resources for a second dose.
Cansino WHO Status
According to the World Health Organization and the world’s leading drug authorities, a vaccine must have at least a 50% protection rate to be considered successful. While CanSino’s statistics appear to be less than the 95 percent protection rate offered by Pfizer Inc. and Moderna Inc. injections, it only takes one shot, not two.
That implies it’s more accurate than Johnson & Johnson’s vaccine, the only other single injection with data from the final testing stage. In a worldwide study, such vaccination was shown to be 66% effective.
EMA approval is given to vaccines that are approved to be used in Europe. While there are many vaccines already approved by the EMA, CanSino is not one of them.
However, this vaccine is under rigorous testing and examination and has already made it to the pre-approval stages with the EMA. Therefore, it is expected that this vaccine will be approved for Europe-wide usage soon.
Countries that have approved CanSino
The following countries have approved the Cansino vaccine for public use:
The vaccines approved by Argentina are Sinopharm, AstraZeneca (Including India’s Covishield), Sputnik V, Gamaleya, and CanSino.
The vaccines approved by Chile are Sinopharm, AstraZeneca (Including India’s Covishield), Gamaleya, Jassen (Johnson and Johnson), and CanSino.
The vaccines approved by China are Anhui Zhifei Longcom, CanSino, SARS-CoV-2 Vaccine (Vero Cells), Sinopharm, and Sinovac.
The vaccines approved by Ecuador are AstraZeneca (Including India’s Covishield), Sputnik V, and CanSino, Pfizer, Sinovac.
The vaccines approved by Hungary are Moderna, Pfizer, CanSino, Sputnik, Johnson, and Johnson, AstraZeneca, and Sinopharm.
The vaccines approved by Malaysia are Moderna, Pfizer, CanSino, Johnson and Johnson, AstraZeneca, and Sinovac, Sinopharm.
The vaccines approved by Mexico are Pfizer, CanSino, Sputnik, Johnson, and Johnson, AstraZeneca, Covaxin, Sinovac.
The vaccines approved by Pakistan are Moderna, Pfizer, CanSino, Sputnik, AstraZeneca, Sinovac, Sinopharm.